RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling

References

• Rosenkranz S. 2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension: a focussed review. Herz. 2023;48(1):23–9. doi:10.1007/s00059-022-05155-1.
   PubMed Web of Science ®Google Scholar
• Hassoun PM, Taichman DB. Pulmonary arterial hypertension. N Engl J Med. 2021;385(25):2361–76. doi:10.1056/NEJMra2000348.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. doi:10.1183/13993003.01913-2018.
   PubMed Web of Science ®Google Scholar
• Ma B, Cao Y, Qin J, Chen Z, Hu G, Li Q. Pulmonary artery smooth muscle cell phenotypic switching: a key event in the early stage of pulmonary artery hypertension. Drug Discov Today. 2023;28(5):103559. doi:10.1016/j.drudis.2023.103559.
   PubMed Web of Science ®Google Scholar
• Nicolais C, Lakhter V, Virk HUH, Sardar P, Bavishi C, O’Murchu B, Chatterjee S. Therapeutic options for in-stent restenosis. Curr Cardiol Rep. 2018;20(2):7. doi:10.1007/s11886-018-0952-4.
   PubMed Web of Science ®Google Scholar
• Masuho I, Balaji S, Muntean BS, Skamangas NK, Chavali S, Tesmer JJG, Babu MM, Martemyanov KA. A global map of G protein signaling regulation by RGS proteins. Cell. 2020;183(2):503–21 e519. doi:10.1016/j.cell.2020.08.052.
   PubMed Web of Science ®Google Scholar
• Almutairi F, Sarr D, Tucker SL, Fantone K, Lee JK, Rada B. RGS10 reduces lethal influenza infection and associated lung inflammation in mice. Front Immunol. 2021;12:772288. doi:10.3389/fimmu.2021.772288.
   PubMedGoogle Scholar
• Qu G, He T, Dai A, Zhao Y, Guan D, Li S, Shi H, Gan W, Zhang A. miR‑199b‑5p mediates adriamycin‑induced podocyte apoptosis by inhibiting the expression of RGS10. Exp Ther Med. 2021;22(6):1469. doi:10.3892/etm.2021.10904.
   PubMed Web of Science ®Google Scholar
• Altman MK, Alshamrani AA, Jia W, Nguyen HT, Fambrough JM, Tran SK, Patel MB, Hoseinzadeh P, Beedle AM, Murph MM, et al. Suppression of the GTPase-activating protein RGS10 increases rheb-GTP and mTOR signaling in ovarian cancer cells. Cancer Lett. 2015;369(1):175–83. doi:10.1016/j.canlet.2015.08.012.
   PubMed Web of Science ®Google Scholar
• Hensch NR, Karim ZA, Druey KM, Tansey MG, Khasawneh FT, Schulz C. RGS10 negatively regulates platelet activation and thrombogenesis. PloS One. 2016;11(11):e0165984. doi:10.1371/journal.pone.0165984.
   PubMed Web of Science ®Google Scholar
• Hu S, Zhao Y, Qiu C, Li Y. RAS protein activator like 2 promotes the proliferation and migration of pulmonary artery smooth muscle cell through AKT/mammalian target of rapamycin complex 1 pathway in pulmonary hypertension. Bioengineered. 2022;13(2):3516–26. doi:10.1080/21655979.2021.1997879.
   PubMed Web of Science ®Google Scholar
• Houssaini A, Abid S, Mouraret N, Wan F, Rideau D, Saker M, Marcos E, Tissot C-M, Dubois-Randé J-L, Amsellem V, et al. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am J Respir Cell Mol Biol. 2013;48(5):568–77. doi:10.1165/rcmb.2012-0429OC.
   PubMed Web of Science ®Google Scholar
• Tang H, Wu K, Wang J, Vinjamuri S, Gu Y, Song S, Wang Z, Zhang Q, Balistrieri A, Ayon RJ, et al. Pathogenic role of mTORC1 and mTORC2 in pulmonary hypertension. JACC Basic Transl Sci. 2018;3(6):744–62. doi:10.1016/j.jacbts.2018.08.009.
   PubMedGoogle Scholar
• Wang W, Liu J, Ma A, Miao R, Jin Y, Zhang H, Xu K, Wang C, Wang J. mTORC1 is involved in hypoxia-induced pulmonary hypertension through the activation of Notch3. J Cell Physiol. 2014;229(12):2117–25. doi:10.1002/jcp.24670.
   PubMed Web of Science ®Google Scholar
• Gu M, Wang Z, Feng F, Yang Y, Sun X, Yang D. Inhibition of PIKfyve ameliorates the proliferation and migration of vascular smooth muscle cells and vascular intima hyperplasia by reducing mTORC1 activity. J Cardiovasc Pharmacol. 2022;79(5):739–48. doi:10.1097/FJC.0000000000001243.
   PubMed Web of Science ®Google Scholar
• Zhou H, Ning Y, Zeng G, Zhou C, Ding X. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT. Oncol Rep. 2021;45(4). doi:10.3892/or.2021.7962.
   Web of Science ®Google Scholar
• Lu QB, Wan MY, Wang PY, Zhang C-X, Xu D-Y, Liao X, Sun H-J. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade. Redox Biol. 2018;14:656–68. doi:10.1016/j.redox.2017.11.012.
   PubMed Web of Science ®Google Scholar
• Sun X, Li S, Gan X, Qiu C, Chen K, Pei H, Wang Q, Li D, Li X, Yang D, et al. Wild-type p53-induced phosphatase 1 promotes vascular smooth muscle cell proliferation and neointima hyperplasia after vascular injury via p-adenosine 5′-monophosphate-activated protein kinase/mammalian target of rapamycin complex 1 pathway. J Hypertens. 2019;37(11):2256–68. doi:10.1097/HJH.0000000000002159.
   PubMed Web of Science ®Google Scholar
• Peng K, Wang M, Wang J, Wang Q, Li D, Sun X, Yang Y, Yang D. Nuclear receptor subfamily 1 group D member 1 suppresses the proliferation, migration of adventitial fibroblasts, and vascular intimal hyperplasia via mammalian target of rapamycin complex 1/β-catenin pathway. Clin Exp Hypertens. 2023;45(1):2178659. doi:10.1080/10641963.2023.2178659.
   PubMed Web of Science ®Google Scholar
• Sun X, Li S, Gan X, Chen K, Yang D, Yang Y. NF2 deficiency accelerates neointima hyperplasia following vascular injury via promoting YAP-TEAD1 interaction in vascular smooth muscle cells. Aging (Albany NY). 2020;12(10):9726–44. doi:10.18632/aging.103240.
   PubMedGoogle Scholar
• Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, et al. A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2011;184(10):1171–82. doi:10.1164/rccm.201103-0412OC.
   PubMed Web of Science ®Google Scholar
• Egan PC, Liang OD, Goldberg LR, Aliotta JM, Pereira M, Borgovan T, Dooner M, Camussi G, Klinger JR, Quesenberry PJ, et al. Low dose 100 cGy irradiation as a potential therapy for pulmonary hypertension. J Cell Physiol. 2019;234(11):21193–98. doi:10.1002/jcp.28723.
   PubMed Web of Science ®Google Scholar
• Wang Z, Gan X, Qiu C, Yang D, Sun X, Zeng Z. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia. Toxicol Appl Pharmacol. 2019;383:114747. doi:10.1016/j.taap.2019.114747.
   PubMed Web of Science ®Google Scholar
• Houssaini A, Abid S, Derumeaux G, Wan F, Parpaleix A, Rideau D, Marcos E, Kebe K, Czibik G, Sawaki D, et al. Selective tuberous sclerosis complex 1 gene deletion in smooth muscle activates mammalian target of rapamycin signaling and induces pulmonary hypertension. Am J Respir Cell Mol Biol. 2016;55(3):352–67. doi:10.1165/rcmb.2015-0339OC.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhong Y, Wang Z. Decrease in tripartite motif containing 24 suppresses hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/mammalian target of rapamycin complex 1 pathway. Bioengineered. 2022;13(5):13596–606. doi:10.1080/21655979.2022.2080423.
   PubMed Web of Science ®Google Scholar
• Lee JK, Chung J, McAlpine FE, Tansey MG. Regulator of G-protein signaling-10 negatively regulates NF-kappaB in microglia and neuroprotects dopaminergic neurons in hemiparkinsonian rats. J Neurosci. 2011;31(33):11879–88. doi:10.1523/JNEUROSCI.1002-11.2011.
   PubMed Web of Science ®Google Scholar
• Yang S, Hao L, McConnell M, Zhou X, Wang M, Zhang Y, Mountz JD, Reddy M, Eleazer PD, Li Y-P, et al. Inhibition of Rgs10 expression prevents immune cell infiltration in bacteria-induced inflammatory lesions and osteoclast-mediated bone destruction. Bone Res. 2013;1(3):267–81. doi:10.4248/BR201303005.
   PubMedGoogle Scholar
• Lee JK, Kannarkat GT, Chung J, Joon Lee H, Graham KL, Tansey MG. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2016;13(1):24. doi:10.1186/s12974-016-0491-0.
   PubMedGoogle Scholar
• Fernandes H, Moura J, Carvalho E. mTOR signaling as a regulator of hematopoietic stem cell fate. Stem Cell Rev And Rep. 2021;17(4):1312–22. doi:10.1007/s12015-021-10131-z.
   PubMed Web of Science ®Google Scholar
• Chrienova Z, Nepovimova E, Kuca K. The role of mTOR in age-related diseases. J Enzyme Inhib Med Chem. 2021;36(1):1679–93. doi:10.1080/14756366.2021.1955873.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–93. doi:10.1016/j.cell.2012.03.017.
   PubMed Web of Science ®Google Scholar